The Dow Jones Industrial Average (^DJI) concluded Monday, November 17, 2025, down 557.24 (-1.18%) points, as investors reacted to a confluence of factors including upcoming earnings reports and a backlog of economic data. The market's main narrative was largely driven by the anticipation of key corporate earnings and the re-emergence of crucial economic indicators following a government shutdown. Market participants are keenly awaiting financial results from chip giant Nvidia (NVDA) later this week, seen as a bellwether for the AI and technology sectors, alongside reports from major retailers like Walmart (WMT) and Home Depot (HD), which will offer insights into consumer health. Additionally, the release of delayed economic data, including the September jobs report on Thursday, is expected to provide a clearer picture of the U.S. economy's health and potentially influence future Federal Reserve policy decisions regarding interest rates.
Individual stock performance within the Dow reflected these broader market sentiments. Among the biggest gainers were Johnson & Johnson (JNJ), rising 2.08%, Amgen (AMGN), up 1.82%, and Merck & Co. (MRK), which climbed 1.11%. These gains suggest a flight to defensive or healthcare-related stocks amidst broader market uncertainty.
Conversely, significant declines were observed in several blue-chip components. American Express (AXP) led the losers, falling 2.37%, partly due to increased U.S. Consumer Card Member loan net write-off rates. IBM (IBM) also saw a notable drop of 2.13%, followed by Salesforce (CRM) at -1.94%, and Apple (AAPL) declining 1.73%. The weakness in technology and financial sectors contributed to the Dow's overall negative performance.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.